| Patents for A61K 49 - Preparations for testing in vivo (35,376) |
|---|
| 08/21/1996 | EP0727225A2 Compositions and methods for directed ultrasound imaging |
| 08/21/1996 | EP0727224A2 Diagnostic agents |
| 08/21/1996 | EP0726781A1 In vivo agents comprising radioactive metal-ion chelates with acidic saccharides and glycosaminoglycans, giving improved site-selective localization, uptake mechanism, sensitivity and kinetic-spatial profiles |
| 08/21/1996 | EP0726762A1 Charged liposome preparation |
| 08/21/1996 | EP0672172A4 Detecting digeorge syndrome mutations. |
| 08/21/1996 | EP0521880B1 Contrast medium containing a non-ionic contrast agent and sodium and calcium salts |
| 08/21/1996 | EP0478727B1 Process for the preparation of aqueous liposome suspensions containing active substances |
| 08/20/1996 | US5547992 Anti-herpes virus and cytomegalovirus polycarbonate oligomers |
| 08/20/1996 | US5547682 Reticulendothelial system contrast agent for use in magnetic resonance imaging |
| 08/20/1996 | US5547656 Low density microspheres and their use as contrast agents for computed tomography, and in other applications |
| 08/20/1996 | EP0737220A4 Copolymers and their use as contrast agents in magnetic resonance imaging and in other applications |
| 08/15/1996 | WO1996024693A1 Methods for testing of therapeutic compounds |
| 08/15/1996 | WO1996024383A1 Nanoparticulate diagnostic dimers as x-ray contrast agents for blood pool and lymphatic system imaging |
| 08/15/1996 | WO1996024382A1 Novel barium salt formulations stabilized by non-ionic and anionic stabilizers |
| 08/15/1996 | WO1996024381A2 Liposomes containing contrast media for blood pool imaging |
| 08/15/1996 | WO1996024357A1 Novel glucocorticoid response elements |
| 08/15/1996 | WO1996024335A1 Sugar base surfactant for nanocrystals |
| 08/15/1996 | CA2212379A1 Novel glucocorticoid response elements |
| 08/15/1996 | CA2212162A1 Liposomes that contain contrast media for the visualization of intravascular space |
| 08/15/1996 | CA2211414A1 Methods for testing of therapeutic compounds |
| 08/15/1996 | CA2206430A1 Sugar base surfactant for nanocrystals |
| 08/14/1996 | EP0725796A1 Growth differentiation factor-10 |
| 08/14/1996 | EP0725633A1 Detection of h. pylori in the stomach |
| 08/13/1996 | US5545617 Therapeutic regulation of abnormal conjunctival goblet cell mucous secretion |
| 08/13/1996 | US5545568 Solid phase and combinatorial synthesis of compounds on a solid support |
| 08/13/1996 | US5545532 Human carcinoma antigen (HCA), HCA antibodies, HCA immunoassays and methods of imaging |
| 08/13/1996 | US5545397 Contrast agents and compositions for radiological imaging, and radiological imaging method utilizing same |
| 08/13/1996 | US5545396 Magnetic resonance imaging using hyperpolarized noble gases |
| 08/13/1996 | US5545395 Method of imaging using encapsulated magnetite particles |
| 08/08/1996 | WO1996023526A2 Diagnostic imaging contrast agents with extended blood retention |
| 08/08/1996 | WO1996023525A1 Diagnostic marker |
| 08/08/1996 | WO1996023524A1 Contrast media for in vivo imaging based on light transmission on reflection |
| 08/08/1996 | CA2539215A1 Diagnostic imaging contrast agents with extended blood retention |
| 08/08/1996 | CA2212257A1 Contrast media for in vivo imaging based on light transmission on reflection |
| 08/08/1996 | CA2211470A1 Diagnostic marker |
| 08/07/1996 | EP0724651A1 Synthetic human neutralizing monoclonal antibodies to human immunodeficiency virus |
| 08/07/1996 | EP0724457A1 Radiation sensitization using texaphyrins |
| 08/07/1996 | EP0724449A1 Preservative for pharmaceutical products |
| 08/07/1996 | EP0576617B1 Composition and method containing optically pure (s) metoprolol |
| 08/07/1996 | CN1128534A Enhanced relaxivity monomeric and multimeric compounds |
| 08/06/1996 | US5543158 Copolymer of polyalkylene glycol and biodegradable polymer selected from polyanhydride, polyhydroxybutyric acid, polycaprolactones, polyorthoesters, polysiloxanes, polyglycolic acid or polylactic acid or copolymer |
| 08/06/1996 | US5543133 Process of preparing x-ray contrast compositions containing nanoparticles |
| 08/06/1996 | US5543132 Oily vehicle, surfactant, viscosity modifying excipient, and water |
| 08/06/1996 | US5543131 HIV-2 strains capable of infecting humans and non-human primates, and infected non-human primates with immune system disease |
| 08/06/1996 | US5542935 Apparatus for making therapeutic containing gas-filled liposomes |
| 08/06/1996 | US5542436 System for use in treating a patient with FK 506 to prevent an adverse immune response |
| 08/06/1996 | CA1338507C Ultrasonic contrast medium made up of small gas bubbles and fatty-acid-containing microparticles |
| 08/01/1996 | WO1996023227A1 Process and compounds for the magnetorelaxometric detection of analytes and use thereof |
| 08/01/1996 | WO1996022994A1 Bismuth compounds |
| 08/01/1996 | WO1996022793A1 Gene transfer for treating a connective tissue of a mammalian host |
| 08/01/1996 | WO1996022787A1 Recombinant human alpha-fetoprotein and uses thereof |
| 08/01/1996 | WO1996022766A1 Sulfated nonionic block copolymer surfactants as stabilizer coatings for nanoparticle compositions |
| 08/01/1996 | WO1996022731A1 Calcium/oxyanion-containing particles for use in medical diagnostic imaging |
| 08/01/1996 | DE19503664A1 Verfahren und Verbindungen zur magnetorelaxometrischen Detektion von Analyten und deren Verwendung Procedure and links magnetorelaxometric detection of analytes and their use |
| 08/01/1996 | CA2211873A1 Bismuth compounds |
| 08/01/1996 | CA2211833A1 Gene transfer for treating a connective tissue of a mammalian host |
| 08/01/1996 | CA2211364A1 Processes and compounds for magnetorelaxometric detection of analytes and their use |
| 08/01/1996 | CA2211098A1 Calcium/oxyanion-containing particles for use in medical diagnostic imaging |
| 07/31/1996 | EP0723553A1 Compounds useful in anti-allergy treatment |
| 07/31/1996 | EP0723458A1 Immune modulation with class ii alpha-chain fragments |
| 07/31/1996 | EP0723450A1 Inhibition of urinary calculi growth |
| 07/31/1996 | EP0513000B1 Mri image enhancement of bone and related tissue using complexes of paramagnetic cations and polyphosphonate ligands |
| 07/31/1996 | CN1128020A Process for the crystallization of iopamidol |
| 07/30/1996 | US5541065 Amplifying nucleic acid sequence from exon two of human leukocyte antigen dpbeta gene in sample, mixing with panel of sequence specific oligonucleotide probes, detecting hybrids formed, determining genotype |
| 07/30/1996 | US5540995 Granular polymer composite and production process thereof as well as diagnostic agent |
| 07/30/1996 | US5540909 Harmonic ultrasound imaging with microbubbles |
| 07/30/1996 | US5540908 Detection of hypoxia with reagents containing 2-nitroimidazole compounds and methods of making such reagents |
| 07/30/1996 | US5540227 Tonometer for applying fluorescein to eyes |
| 07/25/1996 | WO1996022111A1 Local delivery and monitoring of drugs |
| 07/25/1996 | WO1996005209A3 Sialic acid/fucose based medicaments |
| 07/24/1996 | EP0723146A1 Up-converting reporters for biological and other assays using laser excitation techniques |
| 07/24/1996 | EP0723015A1 Novel modified PF4 compositions and methods of use |
| 07/24/1996 | EP0722739A1 Hepatobiliary NMR contrast agents |
| 07/24/1996 | EP0722735A1 Parathyroid hypertensive factor |
| 07/24/1996 | EP0722442A1 Polyazacycloalkanes as dichelants |
| 07/24/1996 | EP0722291A1 Compositions and methods for magnetic resonance imaging, x-ray imaging and radiopharmaceuticals |
| 07/24/1996 | CN1127532A Method for diagnosing a disorder by determining expression of GAGE tumor rejection antigen precursors |
| 07/23/1996 | US5539084 Separation of a specific binding entity for a mixture |
| 07/18/1996 | WO1996021472A1 High-resolution method of imaging part of a biological object using electromagnetic radiation together with a contrast medium |
| 07/18/1996 | DE19500665A1 Verfahren zur ortsauflösenden Abbildung eines Bereiches eines biologischen Objektes mit Hilfe elektromagnetischer Strahlen unter Applikation von Kontrastmittel A method for spatially resolving image of a region of a biological object by means of electromagnetic radiation under application of contrast agent |
| 07/17/1996 | EP0721783A1 Preventive and remedy for diseases caused by fibrinoid or thrombus formation in the lung and model animal for said diseases |
| 07/17/1996 | EP0721353A1 Metal-binding targeted polypeptide constructs |
| 07/17/1996 | EP0721312A1 Use of photodynamic therapy to treat prostatic tissue |
| 07/17/1996 | EP0721311A1 Second sphere complexes as relaxation agents for image enhancement in magnetic resonance imaging |
| 07/17/1996 | CN1127040A Methods and compositions for image contrast enhancing |
| 07/16/1996 | US5536491 19 F poly aza macrocyclic MRI contrast medium |
| 07/16/1996 | US5536490 Ultrasound of vascular systems |
| 07/16/1996 | US5536489 Oil in water, ultrasonic energy |
| 07/11/1996 | WO1996020735A2 Oral gastrointestinal x-ray contrast agents in combination with surfactants |
| 07/11/1996 | WO1996020734A2 Oral gastrointestinal x-ray contrast agents in combination with pharmaceutically acceptable clays and surfactants |
| 07/11/1996 | WO1996014878A3 Calixarene conjugates useful as MRI and CT diagnostic imaging agents |
| 07/11/1996 | WO1996012508A3 Combined use of nucleoside analogues and gene transfection for tissue imaging and therapy |
| 07/11/1996 | WO1996005867A3 Compositions |
| 07/11/1996 | CA2206961A1 Oral gastrointestinal diagnostic x-ray contrast agents in combination with pharmaceutically acceptable clays and surfactants |
| 07/10/1996 | EP0720610A1 Phorbine derivatives and their use in the diagnosis and therapy of cancer |
| 07/10/1996 | EP0720487A1 Composition for use as a negative contrast medium for ultrasonically imaging the gastrointestinal tract |
| 07/10/1996 | EP0639270A4 Phosphorylated contrast agents for mri of the gi tract. |
| 07/10/1996 | EP0609374A4 Contrast agents and compositions for radiological imaging, and radiological imaging method utilizing same. |
| 07/10/1996 | EP0556240B1 Chelating agents |
| 07/10/1996 | CN1126201A Fullfluoralkyl-substituted bezoylguanidine, preparation, parmaceuticle use of same and pharmaceutical containing same |